lidoflazine has been researched along with Coronary Disease in 27 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lidoflazine is a synthetic drug with calcium-channel blocking effects." | 6.65 | The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris. ( Narahara, KA; Park, J; Shapiro, W, 1982) |
| "Lidoflazine is a synthetic drug that appears to be a calcium-entry blocker and results in symptomatic improvement in patients with angina pectoris." | 6.36 | The pathophysiology of angina pectoris and the effect of lidoflazine. ( Gobel, FL; Nelson, RR; Nordstrom, LA; Wang, Y, 1982) |
| "Lidoflazine is a synthetic drug with calcium-channel blocking effects." | 2.65 | The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris. ( Narahara, KA; Park, J; Shapiro, W, 1982) |
| "Lidoflazine is a synthetic drug that appears to be a calcium-entry blocker and results in symptomatic improvement in patients with angina pectoris." | 2.36 | The pathophysiology of angina pectoris and the effect of lidoflazine. ( Gobel, FL; Nelson, RR; Nordstrom, LA; Wang, Y, 1982) |
| "3 Lidoflazine pretreatment inhibited the increase in epicardial ST-segment elevation which resulted, in dogs, from short (3 min) occlusions of the left anterior descending coronary artery." | 1.26 | Lidoflazine in the early stages of acute myocardial ischaemia. ( Coker, SJ; Fagbemi, O; Parratt, JR, 1982) |
| "During 6 months lidoflazine was applied ambulatorily in a dosage of 240 mg/a day orally in 21 patients after finished infarction." | 1.26 | [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease]. ( Lukesch, KH; Schäbitz, J; Schmeisser, M; Teichmann, W; Vogel, HC, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (92.59) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapiro, W | 1 |
| Narahara, KA | 1 |
| Park, J | 1 |
| Gobel, FL | 1 |
| Nordstrom, LA | 1 |
| Nelson, RR | 1 |
| Wang, Y | 1 |
| Coker, SJ | 1 |
| Fagbemi, O | 1 |
| Parratt, JR | 1 |
| Smith, G | 1 |
| Thorburn, JT | 1 |
| Rogers, K | 1 |
| Daenen, W | 2 |
| Flameng, W | 3 |
| Borgers, M | 2 |
| Thone, F | 1 |
| Xhonneux, R | 2 |
| van de Water, A | 1 |
| van Belle, H | 1 |
| Pmerantsev, VP | 1 |
| Ivanova, NA | 1 |
| Zadionchenko, VS | 1 |
| Vertkin, AL | 1 |
| Martynov, AI | 1 |
| Flameng, WJ | 1 |
| Herijgers, P | 1 |
| Szécsi, J | 1 |
| Sergeant, PT | 1 |
| Daenen, WJ | 1 |
| Scheys, I | 1 |
| Wellens, D | 1 |
| De Geest, H | 1 |
| Kesteloot, H | 1 |
| Piessens, J | 1 |
| Lehmann, HU | 3 |
| Ghabussi, P | 1 |
| Hochrein, H | 3 |
| Demin, AA | 1 |
| Balashov, VA | 1 |
| De'Thomatis, M | 1 |
| Falciola, N | 1 |
| Gallesio, R | 1 |
| Teichmann, W | 2 |
| Schäbitz, J | 2 |
| Schmeisser, M | 2 |
| Vogel, H | 1 |
| Lukesch, K | 1 |
| Széplaki, S | 2 |
| Széplaki, Z | 1 |
| Fomina, AA | 1 |
| Mironova, KA | 1 |
| Glomozda, NIa | 1 |
| Klimovich, MD | 1 |
| Vogel, HC | 1 |
| Lukesch, KH | 1 |
| Beck, OA | 1 |
| Myburgh, DP | 1 |
| Liu, GS | 1 |
| Wood, AJ | 1 |
| Isted, K | 1 |
| Hynd, J | 1 |
| Main, MJ | 1 |
| Noble, MI | 1 |
| Parker, J | 1 |
| Drake-Holland, AJ | 1 |
| Scholle, J | 1 |
| Ol'binskaia, LI | 1 |
| Ovchinnikova, LV | 1 |
| Schaper, W | 1 |
| Böszörményi, E | 1 |
| Werkner, J | 1 |
| Szmandra, J | 1 |
| Campese, VM | 1 |
| Marino, A | 1 |
4 reviews available for lidoflazine and Coronary Disease
| Article | Year |
|---|---|
The pathophysiology of angina pectoris and the effect of lidoflazine.
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Coronary Vessels; Heart Rate; Humans; Lidoflazine | 1982 |
Intermittent ischemia of the heart.
Topics: Adenosine; Aorta; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Humans; Lidoflazine; M | 1995 |
Hemodynamic aspects of the treatment of ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium; Cardiac Output; Coronary Disease; Heart Rate; | 1977 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidofl | 1978 |
4 trials available for lidoflazine and Coronary Disease
| Article | Year |
|---|---|
The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Double-Blind Meth | 1982 |
Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Humans; Lidoflazine; | 1979 |
[Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
Topics: Anti-Arrhythmia Agents; Clinical Trials as Topic; Coronary Disease; Heart; Hemodynamics; Humans; Lid | 1977 |
[Controlled study oflidoflazine in ischemic heart disease].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Eval | 1977 |
19 other studies available for lidoflazine and Coronary Disease
| Article | Year |
|---|---|
Lidoflazine in the early stages of acute myocardial ischaemia.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Gas Analysis; Coronary Disease; Coronary Vessels; | 1982 |
Effects of thiopentone on the canine coronary circulation in acute experimental myocardial ischaemia.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; | 1982 |
Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
Topics: Animals; Body Temperature; Coronary Disease; Dogs; Female; Hemodynamics; Lidoflazine; Male; Myocardi | 1981 |
Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
Topics: Animals; Blood Pressure; Body Temperature; Cardiac Output; Cardiopulmonary Bypass; Coronary Disease; | 1981 |
[Ambulatory treatment experience with lidoflazine in ischemic heart disease].
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Coronary Disease; Drug Evaluation; Humans; Lidoflazin | 1980 |
Determinants of early and late results of combined valve operations and coronary artery bypass grafting.
Topics: Age Factors; Aged; Aortic Valve; Coronary Artery Bypass; Coronary Disease; Female; Heart Valve Disea | 1996 |
Clinium used in the treatment of chronic ischaemic cardiac failures.
Topics: Administration, Oral; Ambulatory Care; Angina Pectoris; Chronic Disease; Coronary Disease; Drug Eval | 1975 |
[Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
Topics: Acute Disease; Adult; Aged; Bencyclane; Bradycardia; Chronic Disease; Coronary Circulation; Coronary | 1976 |
[Use of lidoflazin in the treatment of ischemic heart disease].
Topics: Coronary Disease; Humans; Lidoflazine; Piperazines; Vasodilator Agents | 1977 |
[Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
Topics: Animals; Blood Pressure; Chronic Disease; Coronary Disease; Dogs; Drug Evaluation; Drug Tolerance; E | 1976 |
[Acute effect of lidoflazine on the electrocardiographic agitation discharge in atrial frequency stimulation (studies on patients with stress-induced coronary insufficiency)].
Topics: Administration, Oral; Blood Pressure; Bundle of His; Coronary Disease; Electrocardiography; Female; | 1975 |
The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
Topics: Adult; Arrhythmias, Cardiac; Chronic Disease; Coronary Disease; Death, Sudden; Heart Ventricles; Hum | 1975 |
[Protective effects of lidoflazine and mioflazine in ischemic myocardium].
Topics: Animals; Calcium; Cardiovascular Agents; Coronary Disease; Female; Hemodynamics; In Vitro Techniques | 1988 |
Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Dogs; Femal | 1985 |
[The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; | 1974 |
[Dosed physical loading as a method of evaluating the results of treating ischemic heart disease].
Topics: Amines; Angina Pectoris; Coronary Disease; Coumarins; Electrocardiography; Exercise Test; Glycolates | 1972 |
[Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Lidofla | 1973 |
[Electrocardiographic studies on the drug Clinium].
Topics: Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Heart; Humans; Lidoflazine; Male; Midd | 1974 |
[Physio-pharmacology of coronary insufficiency. II].
Topics: Benzofurans; Coronary Disease; Coumarins; Hemodynamics; Humans; Lidoflazine; Monoamine Oxidase Inhib | 1974 |